ASP Isotopes (NASDAQ:ASPI) Stock Price Down 6.2% Following Insider Selling

by · The Cerbat Gem

ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report)’s share price fell 6.2% during trading on Monday after an insider sold shares in the company. The company traded as low as $5.76 and last traded at $5.8370. 955,715 shares were traded during mid-day trading, a decline of 78% from the average session volume of 4,396,342 shares. The stock had previously closed at $6.22.

Specifically, CEO Robert Ainscow sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $5.77, for a total transaction of $144,250.00. Following the transaction, the chief executive officer owned 1,554,693 shares in the company, valued at $8,970,578.61. This trade represents a 1.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Paul Elliot Mann sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $5.77, for a total value of $288,500.00. Following the sale, the insider directly owned 7,921,691 shares in the company, valued at approximately $45,708,157.07. The trade was a 0.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In other ASP Isotopes news, insider Paul Elliot Mann sold 112,500 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $7.51, for a total transaction of $844,875.00. Following the completion of the transaction, the insider directly owned 7,971,691 shares of the company’s stock, valued at approximately $59,867,399.41. This trade represents a 1.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Analysts Set New Price Targets

ASPI has been the subject of several research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Tuesday, November 25th. Loop Capital set a $15.00 price target on ASP Isotopes in a research note on Monday, October 27th. Finally, Canaccord Genuity Group restated a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a report on Monday, November 24th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $13.00.

View Our Latest Research Report on ASP Isotopes

ASP Isotopes Trading Down 7.0%

The business’s 50-day simple moving average is $9.19 and its 200-day simple moving average is $8.82. The company has a market cap of $641.21 million, a PE ratio of -4.46 and a beta of 3.42. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04.

ASP Isotopes (NASDAQ:ASPI – Get Free Report) last issued its earnings results on Wednesday, November 19th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). The firm had revenue of $4.89 million during the quarter, compared to analysts’ expectations of $2.25 million. ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. As a group, analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Institutional Investors Weigh In On ASP Isotopes

A number of large investors have recently bought and sold shares of ASPI. ProShare Advisors LLC raised its position in shares of ASP Isotopes by 12.4% in the third quarter. ProShare Advisors LLC now owns 13,101 shares of the company’s stock valued at $126,000 after purchasing an additional 1,448 shares during the period. Ameritas Investment Partners Inc. grew its stake in ASP Isotopes by 41.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock valued at $40,000 after buying an additional 1,600 shares during the last quarter. Mercer Global Advisors Inc. ADV raised its holdings in ASP Isotopes by 8.3% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock worth $203,000 after acquiring an additional 1,622 shares during the period. The Manufacturers Life Insurance Company lifted its position in ASP Isotopes by 9.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock worth $153,000 after acquiring an additional 1,878 shares during the last quarter. Finally, Legal & General Group Plc lifted its position in ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after acquiring an additional 1,953 shares during the last quarter. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Further Reading